Medicines

For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs.

The medicines listed below are available in Canada, unless otherwise noted. On this page you will find Product Monographs and Patient Medication Information (also known as Consumer Information). You will also find instructions on how to use our devices. Documents provided here are for informational use and for residents of Canada only.

If you are a customer and have questions about Lilly medicines, please call our Customer Response Centre at 1-888-545-5972 or use this online form. If you are seeking medical advice, contact your health care provider.

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

: Bamlanivimab for injection received Notice of Authorization in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

Product Monograph
Patient Medication Information

Additional Information:

Health Care Professional Letter (April 2021)
Health Care Professional Letter (December 2020)

Bamlanivimab Playbook: information for provincial, territorial and local public health programs in planning and implementing the use of bamlanivimab in response to COVID-19 (December 2020)

: Product Monograph
Patient Medication Information
Instructions for Use - Basaglar® KwikPen® (1 to 80 units)

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

Additional Information:
Health Care Professional Letter (June 2006)
Public Communication (June 2006)

: Product Monograph
Patient Medication Information

Additional Information:
Health Care Professional Letter (January 2008)

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

Additional Information:
As per www.drugshortagescanada.ca, Effient has been discontinued in Canada, effective February 10, 2020. Doctors who have an existing Effient patient who cannot be transitioned to another medicine due to medical necessity may apply to Health Canada’s Special Access Programme (SAP) for exceptional access to continued supply. The application form is available at this link.

Health Care Professional Letter (January 2020)
Health Care Professional Letter (January 2014)
Public Communication (January 2014)

: Product Monograph
Patient Medication Information
Instructions for Use - Emgality® 100 mg Single Dose Prefilled Syringe
Instructions for Use - Emgality® 120 mg Single Dose Prefilled Pen
Instructions for Use - Emgality® 120 mg Single Dose Prefilled Syringe

: Product Monograph
Patient Medication Information
Instructions for Use - Entuzity™ KwikPen®

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

Additional Information:
Health Care Professional Letter (May 2006)
Public Communication (May 2006)

: Product Monograph
Patient Medication Information
Instructions for Use - Forteo® 2.4 mL Pen

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information - Humalog® Vials
Patient Medication Information - Humalog® Cartridges
Patient Medication Information - Humalog® KwikPen®
Patient Medication Information - Humalog® Junior KwikPen®
Instructions for Use - Humalog® KwikPen®
Instructions for Use - Humalog® Junior KwikPen®

: Product Monograph
Patient Medication Information - Humalog® 200 units/mL KwikPen®
Instructions for Use - Humalog® 200 units/mL KwikPen®

Additional Information:
Important safety information for HCPs and patients: Humalog® 200 units/mL KwikPen® (September 2015)

: Product Monograph
Patient Medication Information - Humalog® Mix25® Cartridges
Patient Medication Information - Humalog® Mix25® KwikPen®
Instructions for Use - Humalog® Mix25® KwikPen®

: Product Monograph
Patient Medication Information - Humalog Mix50® Cartridges
Patient Medication Information - Humalog Mix50® KwikPen®
Instructions for Use - Humalog Mix50® KwikPen®

: Product Monograph
Patient Medication Information
Instructions for Use - HumatroPen® 6 mg
Instructions for Use - HumatroPen® 12 mg
Instructions for Use - HumatroPen® 24 mg
Hidden Needle Cover User Manual

Additional Information:
Please refer to www.drugshortagescanada.ca for information on the upcoming discontinuation of the Humatrope 5 mg vial.

: Product Monograph
Patient Medication Information - Humulin® N Cartridges and KwikPen®
Patient Medication Information - Humulin® N Vials
Patient Medication Information - Humulin® R Cartridges and KwikPen®
Patient Medication Information - Humulin® R Vials
Patient Medication Information - Humulin® 30/70 Cartridges
Patient Medication Information - Humulin® 30/70 Vials
Instructions for Use - Humulin® N and Humulin® R KwikPen®

: Product Monograph
Patient Medication Information

Additional Information:
Important Safety Information for HCPs and patients: Jardiance® (May 2016)

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

Additional Information:
Health Care Professional Letter (May 2004)

: Product Monograph
Patient Medication Information

Additional Information:
Health Care Professional Letter (Oct 2011)
Health Care Professional Letter (May 2006)
Health Care Professional Letter (Sept 2005)
Health Care Professional Letter (Feb 2005)
Public Communication (Oct 2011)
Public Communication (May 2006)
Public Communication (Sept 2005)
Public Communication (Feb 2005)

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information
Instructions for Use - Taltz® Single-Use Prefilled Autoinjector
Instructions for Use - Taltz® Single-Use Prefilled Syringe

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information
Instructions for Use - Trulicity® Single-Use Pen, 0.75 mg/0.5 mL
Instructions for Use - Trulicity® Single-Use Pen, 1.5 mg/0.5 mL

: Product Monograph
Patient Medication Information

: Product Monograph
Patient Medication Information

Additional Information:
Health Care Professional Letter (Mar 2004)
Public Communication (Mar 2004)

Re-usable Devices – Humalog® and Humulin® Family of Products

Instructions for Use - HumaPen Luxura®
HumaPen Luxura® pens are no longer distributed in Canada.

Instructions for Use - HumaPen Luxura® HD

Instructions for Use - HumaPen Savvio®

® Registered trademark owned by Eli Lilly and Company; used under license.

^TM Trademark owned by Eli Lilly and Company; used under license.

®* Registered trademark of ImClone LLC; used under license.

®+ Registered trademark of Boehringer Ingelheim International GmbH; used under license. Basaglar, Glyxambi, Jardiance, Jentadueto, Synjardy and Trajenta are part of the Boehringer Ingelheim–Lilly Alliance.

®± Registered trademark owned by R.P. Scherer Technologies, Inc., a Catalent Pharma Solutions Company